Markus Loeffler
Direttore Tecnico/Scientifico/R&S presso NH THERAGUIX SAS
Profilo
Markus Loeffler is currently the Chief Medical Officer at NH TherAguix SAS since 2020.
He holds a Master's in Business Administration from INSEAD.
Posizioni attive di Markus Loeffler
| Società | Posizione | Inizio |
|---|---|---|
| NH THERAGUIX SAS | Direttore Tecnico/Scientifico/R&S | 01/01/2020 |
Formazione di Markus Loeffler
| INSEAD | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
NH TherAguix SAS
 NH TherAguix SAS Pharmaceuticals: MajorHealth Technology NH TherAguix SAS operates as a biotechnology company. The firm develops a nanodrug against cancer called AGuIX based on nanometric structuring that allows intravenous injection and the combination of the following properties to fight tumors: targeting, imaging, and treating. The company was founded by G?raldine Le Duc, Olivier Tillement and Fran?ois Lux in on December 11, 2015 and is headquartered in Meylan, France. | Health Technology |
- Borsa valori
- Insiders
- Markus Loeffler
